Michael Belshan

1.1k total citations
37 papers, 813 citations indexed

About

Michael Belshan is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael Belshan has authored 37 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Virology, 22 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in Michael Belshan's work include HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (8 papers). Michael Belshan is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (8 papers). Michael Belshan collaborates with scholars based in United States, France and Tanzania. Michael Belshan's co-authors include Lee Ratner, Christopher J. Destache, Annemarie Shibata, Susan Carpenter, You Zhou, Xiaogang Cheng, Lisa Mahnke, Abhijit A. Date, Christian J. Madson and Subhra Mandal and has published in prestigious journals such as Nature Communications, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Michael Belshan

36 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Belshan United States 20 435 369 249 153 124 37 813
B. J. Potts United States 9 625 1.4× 414 1.1× 213 0.9× 173 1.1× 77 0.6× 14 850
Jason Neidleman United States 18 628 1.4× 519 1.4× 418 1.7× 206 1.3× 65 0.5× 34 1.3k
Pedro M. M. Mesquita United States 21 448 1.0× 556 1.5× 129 0.5× 400 2.6× 39 0.3× 27 1.2k
Melissa Robbiani United States 24 724 1.7× 546 1.5× 174 0.7× 456 3.0× 55 0.4× 54 1.5k
Denys Brand France 20 478 1.1× 401 1.1× 201 0.8× 410 2.7× 64 0.5× 41 1.1k
Sachio Tokiyoshi Japan 11 499 1.1× 228 0.6× 180 0.7× 283 1.8× 119 1.0× 20 770
Rae Ann Spagnuolo United States 13 501 1.2× 345 0.9× 137 0.6× 277 1.8× 44 0.4× 20 976
Chasity D. Andrews United States 13 449 1.0× 512 1.4× 119 0.5× 168 1.1× 30 0.2× 18 840
Richard Stout United States 14 134 0.3× 160 0.4× 171 0.7× 169 1.1× 38 0.3× 21 667
Bettina Stolp Germany 15 370 0.9× 274 0.7× 483 1.9× 141 0.9× 90 0.7× 26 1.1k

Countries citing papers authored by Michael Belshan

Since Specialization
Citations

This map shows the geographic impact of Michael Belshan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Belshan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Belshan more than expected).

Fields of papers citing papers by Michael Belshan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Belshan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Belshan. The network helps show where Michael Belshan may publish in the future.

Co-authorship network of co-authors of Michael Belshan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Belshan. A scholar is included among the top collaborators of Michael Belshan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Belshan. Michael Belshan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watson, Cynthia J., et al.. (2024). Targeted sequencing for hereditary breast and ovarian cancer in BRCA1/2-negative families reveals complex genetic architecture and phenocopies. Human Genetics and Genomics Advances. 5(3). 100306–100306.
2.
Watson, Cynthia J., et al.. (2024). In vitro data suggest a role for PMS2 Kozak sequence mutations in Lynch syndrome risk. Human Genetics and Genomics Advances. 5(3). 100298–100298. 1 indexed citations
3.
He, Wei, Ai‐Yu Gong, Min Li, et al.. (2023). Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses. Nature Communications. 14(1). 1456–1456. 19 indexed citations
4.
Macur, Katarzyna, Shulei Lei, Brenda Morsey, et al.. (2021). SWATH‐MS and MRM: Quantification of Ras‐related proteins in HIV‐1 infected and methamphetamine‐exposed human monocyte‐derived macrophages (hMDM). PROTEOMICS. 21(15). e2100005–e2100005. 4 indexed citations
5.
Belshan, Michael, et al.. (2021). Discovery of candidate HIV-1 latency biomarkers using an OMICs approach. Virology. 558. 86–95. 3 indexed citations
6.
Tso, For Yue, Salum J. Lidenge, John R. Ngowi, et al.. (2021). Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma. PLoS ONE. 16(3). e0247640–e0247640. 43 indexed citations
7.
Mandal, Subhra, Pavan Kumar Prathipati, Michael Belshan, & Christopher J. Destache. (2019). A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study. Antiviral Research. 167. 83–88. 28 indexed citations
8.
Wojtkiewicz, Melinda, et al.. (2018). Proteomic profiling of HIV-infected T-cells by SWATH mass spectrometry. Virology. 516. 246–257. 6 indexed citations
9.
Madson, Christian J., et al.. (2016). Cyclophilin B enhances HIV-1 infection. Virology. 489. 282–291. 23 indexed citations
10.
Haverland, Nicole A., et al.. (2014). Alterations in the nuclear proteome of HIV-1 infected T-cells. Virology. 468-470. 409–420. 13 indexed citations
11.
Sanford, Bridget, Yan Li, Christian J. Madson, et al.. (2014). Deletions in the fifth alpha helix of HIV-1 matrix block virus release. Virology. 468-470. 293–302. 5 indexed citations
12.
Shibata, Annemarie, Alex Pham, Michael Belshan, et al.. (2013). Polymeric Nanoparticles Containing Combination Antiretroviral Drugs for HIV Type 1 Treatment. AIDS Research and Human Retroviruses. 29(5). 746–754. 59 indexed citations
13.
Matthews, John M., et al.. (2012). Knockdown of the Cellular Protein LRPPRC Attenuates HIV-1 Infection. PLoS ONE. 7(7). e40537–e40537. 18 indexed citations
14.
Belshan, Michael, Jason T. Kimata, Charles R. Brown, et al.. (2012). Vpx is Critical for SIVmne infection of pigtail macaques. Retrovirology. 9(1). 32–32. 31 indexed citations
15.
Belshan, Michael, John M. Matthews, & Christian J. Madson. (2010). Replication of biotinylated human immunodeficiency viruses. Journal of Virological Methods. 171(1). 299–302. 2 indexed citations
16.
Belshan, Michael, et al.. (2009). In vivo biotinylation and capture of HIV-1 matrix and integrase proteins. Journal of Virological Methods. 159(2). 178–184. 11 indexed citations
17.
Mahnke, Lisa, Michael Belshan, & Lee Ratner. (2006). Analysis of HIV-2 Vpx by modeling and insertional mutagenesis. Virology. 348(1). 165–174. 13 indexed citations
18.
19.
Belshan, Michael & Lee Ratner. (2003). Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx. Virology. 311(1). 7–15. 28 indexed citations
20.
Belshan, Michael, Prasith Baccam, J. Lindsay Oaks, et al.. (2001). Genetic and Biological Variation in Equine Infectious Anemia Virus Rev Correlates with Variable Stages of Clinical Disease in an Experimentally Infected Pony. Virology. 279(1). 185–200. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. J. Potts Breakdown of academic impact, for papers by Jason Neidleman Breakdown of academic impact, for papers by Pedro M. M. Mesquita Breakdown of academic impact, for papers by Melissa Robbiani Breakdown of academic impact, for papers by Denys Brand Breakdown of academic impact, for papers by Sachio Tokiyoshi Breakdown of academic impact, for papers by Rae Ann Spagnuolo Breakdown of academic impact, for papers by Chasity D. Andrews Breakdown of academic impact, for papers by Richard Stout Breakdown of academic impact, for papers by Bettina Stolp
Rankless by CCL
2026